Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health SystemAlexa K. Dowdell, Brian Piening, Ryan Meng et al.|JCO Oncology Practice|2024Cited by 11
Clinical impact for advanced non-small-cell lung cancer patients tested using comprehensive genomic profiling at a large USA health care systemRyan Meng, Brian Piening, Shu‐Ching Chang et al.|ESMO Real World Data and Digital Oncology|2024Cited by 4
Improved outcomes from reflex comprehensive genomic profiling-guided precision therapeutic selection across a major US healthcare system.Brian Piening, Carlo Bifulco, Bela Bapat et al.|Journal of Clinical Oncology|2023Cited by 3
Widespread adoption of precision anticancer therapies after implementation of pathologist-directed comprehensive genomic profiling across a large US health systemAlexa K. Dowdell, Brian Piening, Ryan Meng et al.|medRxiv|2024Cited by 1
Identification of clinically actionable biomarkers via routine comprehensive genomic profiling across a large community health system.Roshanthi Weerasinghe, Brian Piening, Ryan Meng et al.|Journal of Clinical Oncology|2022Cited by 1